Your browser doesn't support javascript.
loading
Delivery of a sebum modulator by an engineered skin microbe in mice.
Knödlseder, Nastassia; Fábrega, María-José; Santos-Moreno, Javier; Manils, Joan; Toloza, Lorena; Marín Vilar, Maria; Fernández, Cristina; Broadbent, Katrina; Maruotti, Julien; Lemenager, Hélène; Carolis, Carlo; Zouboulis, Christos C; Soler, Concepció; Lood, Rolf; Brüggemann, Holger; Güell, Marc.
Afiliação
  • Knödlseder N; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Fábrega MJ; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Santos-Moreno J; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Manils J; Immunity, Inflammation and Cancer Group, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain.
  • Toloza L; Serra Húnter Programme, Immunology Unit, Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Marín Vilar M; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Fernández C; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Broadbent K; Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Maruotti J; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Lemenager H; Protein Technologies Facility, Center of Genomic Regulation, Barcelona, Spain.
  • Carolis C; Phenocell SAS, Grasse, France.
  • Zouboulis CC; Phenocell SAS, Grasse, France.
  • Soler C; Protein Technologies Facility, Center of Genomic Regulation, Barcelona, Spain.
  • Lood R; Hochschulklinik für Dermatologie, Venerologie und Allergologie, Immunologisches Zentrum; Städtisches Klinikum Dessau; and Medizinische Hochschule Brandenburg Theodor Fontane und Fakultät für Gesundheitswissenschaften Brandenburg, Dessau-Roßlau, Germany.
  • Brüggemann H; Immunity, Inflammation and Cancer Group, Oncobell Program, Institut d'Investigació Biomèdica de Bellvitge, Barcelona, Spain.
  • Güell M; Immunology Unit, Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona, Barcelona, Spain.
Nat Biotechnol ; 2024 Jan 09.
Article em En | MEDLINE | ID: mdl-38195987
ABSTRACT
Microorganisms can be equipped with synthetic genetic programs for the production of targeted therapeutic molecules. Cutibacterium acnes is the most abundant commensal of the human skin, making it an attractive chassis to create skin-delivered therapeutics. Here, we report the engineering of this bacterium to produce and secrete the therapeutic molecule neutrophil gelatinase-associated lipocalin, in vivo, for the modulation of cutaneous sebum production.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Biotechnol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Biotechnol Ano de publicação: 2024 Tipo de documento: Article